Interestingly, DR2 expression levels in somatotrophs are correlated with dopamine agonist response rates both in vitro and in vivo, and analysis of prolactin and DR2 expression patterns within GH-secreting adenomas has been proposed as a guide for pharmacotherapy strategies in acromegaly patients (28–31). Here, PRL is linked to adenoma.